Advertisement

Topics

Converging blockchain and next-generation AI technologies to accelerate biomedical research

19:00 EST 14 Nov 2017 | AAAS

(InSilico Medicine, Inc.) Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery announced the publication of the latest development of converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.

Original Article: Converging blockchain and next-generation AI technologies to accelerate biomedical research

NEXT ARTICLE

More From BioPortfolio on "Converging blockchain and next-generation AI technologies to accelerate biomedical research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...